Author

Rajesh Kumar Ramalingam

Observed names: Rajesh Kumar, Rajesh Ramalingam

Institution: Viatris

Observed institutions: GlaxoSmithKline (India), Viatris

ORCID: 0000-0003-0690-1283

Observed ORCID: 0000-0003-0690-1283

OpenAlex ID: A5010962668

A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis

2023 · Bing Zhou, Lei Cheng, et al. · Pulmonary Therapy · 10

Tackling AMR crisis in India: Changing paradigm

2020 · Sandeep Lahiry, Rajesh Ramalingam, et al. · Asian Journal of Medical Sciences · 10

A double-blind, placebo-controlled trial of the efficacy and safety of two doses of azelastine hydrochloride in perennial allergic rhinitis

2023 · Jean Bousquet, Ludger Klimek, et al. · Frontiers in Allergy · 9

In perennial allergic rhinitis, RQLQ is improved similarly by Azelastine 0.15 and mometasone furoate

2025 · Jean Bousquet, Ludger Klimek, et al. · World Allergy Organization Journal · 3

Determination of the Bioavailability of 3 Intranasal Formulations of Azelastine Hydrochloride in Healthy Male Volunteers

2025 · Jean Bousquet, Ludger Klimek, et al. · Clinical Pharmacology in Drug Development · 2

An Observational Study to Determine the Real-Life Effectiveness of MP-AzeFlu in Asian Patients with Allergic Rhinitis

2026 · Pongsakorn Tantilipikorn, Yau Kay Chung Julian, et al. · Drugs - Real World Outcomes · 1

Introduction of MP-AzeFlu nasal spray for individuals with allergic rhinitis in Saudi Arabia and the United Arab Emirates: a budget impact analysis

2025 · Jatin Agarwal, Rajesh Kumar Ramalingam, et al. · Current Medical Research and Opinion · 1

Double-Blind, Placebo-Controlled Trial of the Efficacy and Safety of Azelastine Hydrochloride in Children with Perennial Allergic Rhinitis

2024 · Jean Bousquet, Ludger Klimek, et al. · International Archives of Allergy and Immunology · 1

The Comparative Bioavailability of Fluticasone and Azelastine Delivered as a Single Fixed Dose Combination (MP-AzeFlu) in Comparison to Two Different Formulations of Azelastine and Fluticasone Propionate Following Intranasal Administration in Healthy Chinese Volunteers

2023 · Wenyuan Qi, Yue Liu, et al. · Journal of Asthma and Allergy · 1

Onset of Action of Azelastine 0.15% Versus Olopatadine/Mometasone for Allergen‐Induced Rhinitis: An EEU Crossover Study

2026 · Jean Bousquet, Ludger Klimek, et al. · Clinical and Translational Allergy

Correction: A Clinical Study to Assess the Efficacy and Safety of MP-AzeFlu Nasal Spray in Comparison to Commercially Available Azelastine Hydrochloride and Fluticasone Propionate Nasal Sprays in Chinese Volunteers with Allergic Rhinitis

2023 · Bing Zhou, Lei Cheng, et al. · Pulmonary Therapy

Development and validation of a stability-indicating RP-HPLC method for the simultaneous quantification of Olmesartan Medoxomil and Chlorthalidone insolid dosage form

2014 · Pratap Murali, P. Sunil Kumar Chaitanya, et al. · Der pharmacia lettre

Works count: 12

Citation count: 38

H-index: 3

I10-index: 2